• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥术、瓣膜手术和经皮介入治疗的临床疗效比较及死亡风险

Comparative clinical outcomes and mortality risk in coronary artery bypass grafting, valve surgeries, and percutaneous interventions.

作者信息

Faizabadi Sanam, Farshid Amirali, Dadkhah Parisa Alsadat, Yaghoubi Shayan, Khademi Reza, Zebardast Khorrami Shakiba, Asadi Alireza, Garmsiri Arta, Zabihi Nima, Khazaei Pool Sareh, Talebian Niki, Falah Tafti Mahdi, Alizadeh Alaleh, Asadi Anar Mahsa, Deravi Niloofar

机构信息

Student Research Committee, Faculty of Medicine, Shiraz University of Medical Sciences Shiraz, Iran.

Student Research Committee, School of Medicine, Ardabil University of Medical Sciences Ardabil, Iran.

出版信息

Am J Cardiovasc Dis. 2025 Jun 15;15(3):195-211. doi: 10.62347/TYLZ6475. eCollection 2025.

DOI:10.62347/TYLZ6475
PMID:40689061
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12267080/
Abstract

OBJECTIVES

Coronary artery disease and valvular heart disease are leading causes of mortality globally. This study aimed to investigate the correlation between expected mortality rates (EMRs) and observed mortality rates (OMRs) for common cardiac interventions using recent national data on percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and cardiac valve surgeries.

METHODS

This multi-institutional, retrospective observational study analyzed in-hospital/30-day mortality outcomes for 106,836 patients who underwent PCI, CABG, or cardiac valve procedures across 64 non-federal hospitals in New York State between December 2012 and November 2015. The procedures included emergency and non-emergency PCI, CABG, valve or valve-CABG surgeries, and transcatheter aortic valve replacement (TAVR).

RESULTS

Among the 106,836 patients, a 3.21% 30-day mortality rate was observed (n=3,436). To assess the disparity between OMR and EMR, a one-sample t-test was performed. Effect sizes were determined using Cohen's d and Hedges' correction. With a 95% confidence interval, the t-value for the OMR (mean difference =2.037±1.728, CI: 1.95-2.12) was 47.270, whereas the EMR (mean difference =1.930±1.284, CI: 1.86-1.99) yielded a t-value of 60.279. The OMR was significantly greater than the EMR (P<0.001).

CONCLUSION

The OMR was significantly greater than the EMR across all cardiac procedures, suggesting potential influences from patient demographics, comorbidities, and variations in hospital practices. Further research is needed to understand these factors and improve the quality of cardiac care.

摘要

目的

冠状动脉疾病和心脏瓣膜病是全球主要的死亡原因。本研究旨在利用近期关于经皮冠状动脉介入治疗(PCI)、冠状动脉旁路移植术(CABG)和心脏瓣膜手术的全国数据,调查常见心脏干预措施的预期死亡率(EMR)与观察到的死亡率(OMR)之间的相关性。

方法

这项多机构回顾性观察研究分析了2012年12月至2015年11月期间纽约州64家非联邦医院中106,836例接受PCI、CABG或心脏瓣膜手术患者的住院/30天死亡率结果。这些手术包括急诊和非急诊PCI、CABG、瓣膜或瓣膜 - CABG手术以及经导管主动脉瓣置换术(TAVR)。

结果

在106,836例患者中,观察到30天死亡率为3.21%(n = 3,436)。为评估OMR和EMR之间的差异,进行了单样本t检验。使用Cohen's d和Hedges'校正确定效应大小。在95%置信区间下,OMR的t值(平均差异 = 2.037±1.728,CI:1.95 - 2.12)为47.270,而EMR(平均差异 = 1.930±1.284,CI:1.86 - 1.99)的t值为60.279。OMR显著高于EMR(P<0.001)。

结论

在所有心脏手术中,OMR均显著高于EMR,这表明患者人口统计学特征、合并症以及医院实践差异可能产生影响。需要进一步研究以了解这些因素并改善心脏护理质量。

相似文献

1
Comparative clinical outcomes and mortality risk in coronary artery bypass grafting, valve surgeries, and percutaneous interventions.冠状动脉搭桥术、瓣膜手术和经皮介入治疗的临床疗效比较及死亡风险
Am J Cardiovasc Dis. 2025 Jun 15;15(3):195-211. doi: 10.62347/TYLZ6475. eCollection 2025.
2
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
3
Transcatheter Versus Surgical Approach for the Treatment of Aortic Stenosis in Patients With Concomitant Coronary Artery Disease: A Systematic Review and Meta-Analysis.经导管与外科手术治疗合并冠状动脉疾病的主动脉瓣狭窄患者:系统评价与荟萃分析
Catheter Cardiovasc Interv. 2025 Jul 1. doi: 10.1002/ccd.31697.
4
Preoperative coronary interventions for preventing acute myocardial infarction in the perioperative period of major open vascular or endovascular surgery.术前冠状动脉介入治疗预防大型开放性血管或血管内手术后围手术期急性心肌梗死。
Cochrane Database Syst Rev. 2024 Jul 3;7(7):CD014920. doi: 10.1002/14651858.CD014920.pub2.
5
Ten-year outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for multivessel or left main coronary artery disease: a systematic review and meta-analysis.多支血管病变或左主干冠状动脉疾病行经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗 10 年的结局:系统评价和荟萃分析。
J Cardiothorac Surg. 2023 Feb 2;18(1):54. doi: 10.1186/s13019-023-02101-y.
6
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
7
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
8
Exercise-based cardiac rehabilitation for coronary heart disease.基于运动的冠心病心脏康复。
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
9
Psychological interventions for coronary heart disease.冠心病的心理干预措施。
Cochrane Database Syst Rev. 2017 Apr 28;4(4):CD002902. doi: 10.1002/14651858.CD002902.pub4.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.

本文引用的文献

1
Sex, Atrial Fibrillation, and Long-Term Mortality After Cardiac Surgery.性别、心房颤动与心脏手术后的长期死亡率。
JAMA Netw Open. 2024 Aug 1;7(8):e2426865. doi: 10.1001/jamanetworkopen.2024.26865.
2
Association between Complications and Death within 30 days after General Surgery: A Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) substudy.普通外科手术后30天内并发症与死亡之间的关联:非心脏手术患者血管事件队列评估(VISION)子研究
Ann Surg. 2024 Jun 11. doi: 10.1097/SLA.0000000000006372.
3
Comparing outcomes between coronary artery bypass grafting and percutaneous coronary intervention in octogenarians with left main or multivessel disease.比较左主干或多支血管病变的 80 岁以上高龄患者行冠状动脉旁路移植术与经皮冠状动脉介入治疗的结局。
Sci Rep. 2023 Dec 15;13(1):22323. doi: 10.1038/s41598-023-49069-2.
4
A Systematic Review of Individualized Heart Surgery with a Personalized Prosthesis.个性化人工心脏瓣膜个体化心脏手术的系统评价
J Pers Med. 2023 Oct 11;13(10):1483. doi: 10.3390/jpm13101483.
5
Volume-Outcome Relationship in Surgical and Cardiac Transcatheter Interventions with a Focus on Transcatheter Aortic Valve Implantation.外科手术及心脏导管介入治疗中的容量-结局关系,重点关注经导管主动脉瓣植入术
J Clin Med. 2022 Jun 30;11(13):3806. doi: 10.3390/jcm11133806.
6
Factors affecting mortality after coronary bypass surgery: a scoping review.影响冠状动脉旁路手术后死亡率的因素:范围综述。
J Cardiothorac Surg. 2022 Mar 21;17(1):45. doi: 10.1186/s13019-022-01784-z.
7
A National Evaluation of Emergency Cardiac Surgery After Percutaneous Coronary Intervention and Postsurgical Patient Outcomes.经皮冠状动脉介入治疗后紧急心脏手术的全国评估及术后患者结局。
Am J Cardiol. 2020 Sep 1;130:24-29. doi: 10.1016/j.amjcard.2020.05.041. Epub 2020 Jun 7.
8
Deep Learning for Improved Risk Prediction in Surgical Outcomes.深度学习在手术结局风险预测中的应用。
Sci Rep. 2020 Jun 9;10(1):9289. doi: 10.1038/s41598-020-62971-3.
9
Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.左主干冠状动脉疾病经皮冠状动脉介入治疗或冠状动脉旁路移植术后 5 年的结果。
N Engl J Med. 2019 Nov 7;381(19):1820-1830. doi: 10.1056/NEJMoa1909406. Epub 2019 Sep 28.
10
Measuring quality outcomes across hospital systems: Using a claims data model for risk adjustment of mortality rates.测量医院系统的质量结果:使用索赔数据模型调整死亡率的风险。
S Afr Med J. 2019 Apr 29;109(5):299-305. doi: 10.7196/SAMJ.2019.v109i5.13775.